Tumor cell-derived Hsp90 exhibits a 100-fold higher binding affinity for 17-AAG than that from normal cells, since tumor cell-derived Hsp90 complexes with activating co-chaperones p23 and HOP exhibit increased ATPase activity and possess higher affinity to Hsp90 inhibitors. This evidence concerns the gene HSP90AA1 and neoplasm.